Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-163

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 40 mg (71610 0163 15)

Label for Atorvastatin Calcium 40 mg oral film-coated tablets, containing 15 tablets. Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY, and repackaged by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. Includes NDC number 71610-0163-15 and storage instructions.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure-01 (Figure 01)

A line graph showing cumulative incidence (%) over time (years) comparing Atorvastatin and Placebo. Two lines represent data trends, with Atorvastatin showing a lower cumulative incidence than Placebo across approximately 3.5 years. Statistical results including hazard ratio (HR) and p-value are noted below the graph.*

FDA Label Image

Figure-02 (Figure 02)

A line graph showing cumulative hazard percentages over time (years) up to 5 years comparing placebo and atorvastatin. The graph illustrates a lower cumulative hazard for atorvastatin compared to placebo, with hazard ratio and p-value indicated in the lower right.*

FDA Label Image

Figure-03 (Figure 03)

This line graph compares the percentage of subjects experiencing a major cardiovascular event over a five-year period on atorvastatin 10 mg versus atorvastatin 80 mg. The x-axis shows time in years to first event, and the y-axis shows the percentage of subjects affected. The graph indicates a lower event rate for the 80 mg dose versus the 10 mg dose, with a hazard ratio of 0.78 (0.69-0.89) and p-value of 0.0002.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of atorvastatin calcium, illustrating the molecular components and arrangement of the active ingredient atorvastatin in its calcium salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.